Clinical Trials in Wisconsin

Are you looking to enroll in a clinical trial in Wisconsin? With new trials like "Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver" and "Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma", the Badger State has established itself as a great location for clinical research studies, particularly in cities like Madison and Milwaukee.

While some individuals are looking for paid clinical trials, others want to help advance gastroenterology and psychology clinical research in Wisconsin. To begin your search for Wisconsin clinical trials, use the form on the right.

Use our guide to learn which trials are right for you!


We've found
5,821
clinical trials in
Wisconsin

Oncology, Reproductive Clinical Trial
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
West Allis, WI
Click here to add this to my saved trials
Infections, Papillomavirus Clinical Trial
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Subjects With Unresectable or Metastatic Melanoma (CheckMate 218)
Status: Enrolling
Updated: 3/17/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ H2N- Advanced Breast Cancer
Status: Enrolling, Phase II
Updated: 3/17/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Chippewa Falls, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Grafton, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Ladysmith, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Marshfield, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Waukesha, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Wausau, WI
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/18/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Status: Enrolling
Updated: 3/18/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 3/21/2016
mi
from
Johnson Creek, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Fond Du Lac, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Marinette, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Wausau, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase II
Updated: 3/22/2016
mi
from
Weston, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
Status: Enrolling
Updated: 3/22/2016
mi
from
Summit, WI
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Status: Enrolling
Updated: 3/22/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Status: Enrolling, Phase IV
Updated: 3/23/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Status: Enrolling, Phase IV
Updated: 3/23/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
Status: Enrolling, Phase III
Updated: 3/24/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
Status: Enrolling, Phase III
Updated: 3/24/2016
mi
from
Onalaska, WI
Click here to add this to my saved trials
Severe Open Fractures of the Tibia (Shin) Bone Clinical Trial
Assessment of Fixation Strategies for Severe Open Tibia Fractures
Status: Enrolling, Phase III
Updated: 3/24/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling
Updated: 3/24/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematopoietic Stem Cell Transplantation Clinical Trial
Phase II Open Label Trial Of Tacrolimus/Methotrexate And Tocilizumab For The Prevention Of Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling, Phase II
Updated: 3/25/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Epilepsies, Partial Clinical Trial
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Status: Enrolling, Phase IV
Updated: 3/28/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Exocrine Pancreatic Insufficiency Clinical Trial
Study to Evaluate Safety, Tolerability and Fat Absorption Using a Novel Enteral Feeding In-line Digestive Enzyme Cartridge (Relizorb)
Status: Enrolling
Updated: 3/28/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 3/29/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 3/29/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Chippewa Falls, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Grafton, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Marshfield, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Waukesha, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Behavioral Activation for Smoking Cessation in PTSD
Status: Enrolling
Updated: 3/30/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Asthma Clinical Trial
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma
Status: Enrolling, Phase III
Updated: 3/31/2016
mi
from
Greenfield, WI
Click here to add this to my saved trials
Asthma Clinical Trial
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Glioblastoma Clinical Trial
A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
Status: Enrolling, Phase III
Updated: 3/31/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Virus Diseases Clinical Trial
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
Status: Enrolling, Phase II
Updated: 3/31/2016
mi
from
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Antigo, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
West Allis, WI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 4/4/2016
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Mequon, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 4/4/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis Clinical Trial
Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I Trial of Afatinib in Pediatric Tumours
Status: Enrolling, Phase I
Updated: 4/4/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Grafton, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 58
View Clinical Trial Facilties in Wisconsin